Sévrine Broxer
About Sévrine Broxer
Sévrine Broxer is the Associate Director of Global Manufacturing and Supply, Business Development at Bristol-Myers Squibb in New York, with over 20 years of experience in various roles within the company.
Title
Sévrine Broxer serves as the Associate Director, Global Manufacturing and Supply, Business Development at Bristol-Myers Squibb. She is responsible for overseeing business development aspects in the manufacturing and supply domains at the global level from their New York, New York office.
Current Role at Bristol-Myers Squibb
In her current role as Associate Director at Bristol-Myers Squibb, Sévrine Broxer manages global manufacturing and supply business development. This includes strategizing and implementing plans to enhance supply chain operations and integrate business development goals to ensure efficient manufacturing processes.
Previous Roles at Bristol-Myers Squibb
Sévrine Broxer has held several roles at Bristol-Myers Squibb, including Category Manager for Active Intermediates and Chemicals, Drug Product Development and Commercial between 2013 and 2015, and Senior Sourcing Manager from 2009 to 2013. Earlier, she worked as a Research Scientist from 2001 to 2008. Her progression within the company from scientific roles to business and sourcing management underscores a versatile skill set.
Education and Expertise
Sévrine Broxer has a robust educational background with degrees from notable institutions. She earned a Master of Business Administration (MBA) from Rutgers University, a Master of Science from The Ohio State University, and a Bachelor of Science from CPE Lyon in France. This education forms the backbone of her expertise, combining business and scientific knowledge.
Overall Experience
Sévrine Broxer brings over 20 years of experience to her role at Bristol-Myers Squibb. Her career spans various domains including research, sourcing, business development, and manufacturing. She also worked at DuPont Pharmaceuticals as a Staff Scientist prior to her long tenure at Bristol-Myers Squibb. This extensive background enables her to navigate complex intersections between science and business.